NO20015753D0 - Poröse legemiddelmatriser og fremgangsmåter for deres fremstilling - Google Patents

Poröse legemiddelmatriser og fremgangsmåter for deres fremstilling

Info

Publication number: NO20015753D0
Authority: NO; Norway
Prior art keywords: drug; porous matrix; forming agent; pore forming; volatile
Prior art date: 1999-05-27

Application number

NO20015753A

Other languages

English (en)

Other versions

NO20015753L (no

NO323761B1 (no

Inventor

Julie Straub

Howard Bernstein

Iii Donald E Chickering

Sarwat Khatak

Greg Randall

Original Assignee

Acusphere Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-27

Filing date

2001-11-26

Publication date

2001-11-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27495210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20015753(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-04 Priority claimed from US09/433,486 external-priority patent/US6395300B1/en

2001-11-26 Application filed by Acusphere Inc filed Critical Acusphere Inc

2001-11-26 Publication of NO20015753D0 publication Critical patent/NO20015753D0/no

2002-01-28 Publication of NO20015753L publication Critical patent/NO20015753L/no

2007-07-02 Publication of NO323761B1 publication Critical patent/NO323761B1/no

Links

229940079593 drug Drugs 0.000 title abstract 14
239000003814 drug Substances 0.000 title abstract 14
238000000034 method Methods 0.000 title abstract 2
239000011159 matrix material Substances 0.000 abstract 7
239000002904 solvent Substances 0.000 abstract 5
239000003795 chemical substances by application Substances 0.000 abstract 4
239000011148 porous material Substances 0.000 abstract 4
ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 abstract 2
229930012538 Paclitaxel Natural products 0.000 abstract 2
239000012736 aqueous medium Substances 0.000 abstract 2
239000002775 capsule Substances 0.000 abstract 2
238000004090 dissolution Methods 0.000 abstract 2
229960003668 docetaxel Drugs 0.000 abstract 2
239000000839 emulsion Substances 0.000 abstract 2
239000011859 microparticle Substances 0.000 abstract 2
229960001592 paclitaxel Drugs 0.000 abstract 2
238000010561 standard procedure Methods 0.000 abstract 2
239000000725 suspension Substances 0.000 abstract 2
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 1
239000003684 drug solvent Substances 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
238000001694 spray drying Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Epoxy Compounds (AREA)

NO20015753A 1999-05-27 2001-11-26 Fremgangsmate for fremstilling av en poros matrise av legemiddel samt farmasoytisk preparat omfattende denne. NO323761B1 (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US13632399P	1999-05-27	1999-05-27
US15865999P	1999-10-08	1999-10-08
US09/433,486 US6395300B1 (en)	1999-05-27	1999-11-04	Porous drug matrices and methods of manufacture thereof
US18631000P	2000-03-02	2000-03-02
PCT/US2000/014578 WO2000072827A2 (en)	1999-05-27	2000-05-25	Porous drug matrices and methods of manufacture thereof

Publications (3)

Publication Number	Publication Date
NO20015753D0 true NO20015753D0 (no)	2001-11-26
NO20015753L NO20015753L (no)	2002-01-28
NO323761B1 NO323761B1 (no)	2007-07-02

Family

ID=27495210

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20015753A NO323761B1 (no)	1999-05-27	2001-11-26	Fremgangsmate for fremstilling av en poros matrise av legemiddel samt farmasoytisk preparat omfattende denne.

Country Status (18)

Country	Link
EP (1)	EP1180020B2 (no)
JP (1)	JP4722295B2 (no)
KR (2)	KR100883477B1 (no)
CN (1)	CN1240373C (no)
AT (1)	ATE312601T1 (no)
AU (1)	AU768022B2 (no)
BR (1)	BR0010984A (no)
CA (1)	CA2371836C (no)
DE (1)	DE60024811T3 (no)
DK (1)	DK1180020T4 (no)
ES (1)	ES2250141T5 (no)
HK (1)	HK1048956B (no)
IL (2)	IL146659A0 (no)
MX (1)	MXPA01012106A (no)
NO (1)	NO323761B1 (no)
NZ (1)	NZ516083A (no)
TW (1)	TWI274589B (no)
WO (1)	WO2000072827A2 (no)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6342533B1 (en)	1998-12-01	2002-01-29	Sepracor, Inc.	Derivatives of (−)-venlafaxine and methods of preparing and using the same
CZ20013607A3 (cs)	1999-04-06	2002-06-12	Sepracor Inc.	Farmaceutický prostředek
US8771740B2 (en) *	1999-12-20	2014-07-08	Nicholas J. Kerkhof	Process for producing nanoparticles by spray drying
AR035642A1 (es) *	2000-05-26	2004-06-23	Pharmacia Corp	Uso de una composicion de celecoxib para el alivio rapido del dolor
US6589557B2 (en) *	2000-06-15	2003-07-08	Acusphere, Inc.	Porous celecoxib matrices and methods of manufacture thereof
US6514482B1 (en)	2000-09-19	2003-02-04	Advanced Inhalation Research, Inc.	Pulmonary delivery in treating disorders of the central nervous system
US6613308B2 (en)	2000-09-19	2003-09-02	Advanced Inhalation Research, Inc.	Pulmonary delivery in treating disorders of the central nervous system
DE10059020A1 (de) *	2000-11-28	2002-05-29	Gruenenthal Gmbh	Parenteral applizierbare Darreichungsformen
MXPA03005655A (es)	2000-12-21	2004-12-03	Nektar Therapeutics	Liberacion pulmonar de agentes antifungicos de polieno.
US7115565B2 (en)	2001-01-18	2006-10-03	Pharmacia & Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
MXPA03006404A (es) *	2001-01-18	2004-12-02	Upjohn Co	Composiciones quimioterapeuticas de microemulsion de paclitaxel con biodisponibilidad oral mejorada.
BR0207157A (pt) †	2001-02-12	2004-02-17	Wyeth Corp	Sal de succinato de o-desmetil-venlafaxina
US7585493B2 (en)	2001-05-24	2009-09-08	Alexza Pharmaceuticals, Inc.	Thin-film drug delivery article and method of use
US7766013B2 (en)	2001-06-05	2010-08-03	Alexza Pharmaceuticals, Inc.	Aerosol generating method and device
US7458374B2 (en)	2002-05-13	2008-12-02	Alexza Pharmaceuticals, Inc.	Method and apparatus for vaporizing a compound
US20070122353A1 (en)	2001-05-24	2007-05-31	Hale Ron L	Drug condensation aerosols and kits
US7090830B2 (en)	2001-05-24	2006-08-15	Alexza Pharmaceuticals, Inc.	Drug condensation aerosols and kits
CA2446904A1 (en)	2001-05-24	2003-04-03	Alexza Molecular Delivery Corporation	Delivery of drug esters through an inhalation route
WO2002094231A1 (en) *	2001-05-24	2002-11-28	Alexza Molecular Delivery Corporation	Delivery of analgesics through an inhalation route
WO2003007968A1 (en) *	2001-07-17	2003-01-30	Sun Pharmaceutical Industries Ltd.	A cardiotonic composition
WO2003041693A1 (en) *	2001-11-09	2003-05-22	Alexza Molecular Delivery Corporation	Delivery of diazepam through an inhalation route
US7005138B2 (en) *	2001-12-21	2006-02-28	Duramed Pharmaceuticals, Inc.	Method of systematically delivering SSRIs
LT2630954T (lt) *	2002-03-20	2017-01-25	Civitas Therapeutics, Inc.	Levodopos įvedimas į plaučius
JP4452970B2 (ja) *	2002-03-27	2010-04-21	日本臓器製薬株式会社	ジクロフェナクナトリウム経口製剤
US9060941B2 (en)	2002-09-20	2015-06-23	Actavis, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en)	2002-09-20	2011-12-27	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en)	2002-09-20	2011-06-14	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en)	2002-09-20	2010-08-31	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8980870B2 (en)	2002-09-24	2015-03-17	Boehringer Ingelheim International Gmbh	Solid telmisartan pharmaceutical formulations
CN1694689A (zh) *	2002-09-30	2005-11-09	阿库斯菲尔公司	供吸入的缓释多孔微粒
JP5064794B2 (ja)	2003-03-31	2012-10-31	タイタンファーマシューティカルズインコーポレイテッド	ドパミンアゴニストの徐放のための移植可能なポリマーデバイス
US7306812B2 (en)	2003-05-09	2007-12-11	Cephalon, Inc.	Dissolvable backing layer for use with a transmucosal delivery device
US7276246B2 (en)	2003-05-09	2007-10-02	Cephalon, Inc.	Dissolvable backing layer for use with a transmucosal delivery device
JP2007516404A (ja)	2003-05-21	2007-06-21	アレックザファーマシューティカルズ，インコーポレイテッド	光学点火されたかまたは電気点火された内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット
GB0401947D0 (en)	2004-01-28	2004-03-03	Unilever Plc	Porous bodies and method of production thereof
KR100681660B1 (ko) *	2004-03-17	2007-02-09	주식회사종근당	방출제어 펠릿의 약제학적 조성물
US7540286B2 (en)	2004-06-03	2009-06-02	Alexza Pharmaceuticals, Inc.	Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP2246086A3 (en)	2004-08-12	2012-11-21	Alexza Pharmaceuticals, Inc.	Aerosol drug delivery device incorporating percussively activated heating unit
GB0425758D0 (en)	2004-11-23	2004-12-22	Vectura Ltd	Preparation of pharmaceutical compositions
EP1681056A1 (en) *	2005-01-14	2006-07-19	Krka Tovarna Zdravil, D.D., Novo Mesto	Process for preparing lansoprazole
WO2007004236A2 (en) *	2005-07-04	2007-01-11	Ramu Krishnan	Improved drug or pharmaceutical compounds and a preparation thereof
GB0517688D0 (en) *	2005-08-31	2005-10-05	Cambridge Biostability Ltd	Improvements in the stabilisation of biological materials
GB0523638D0 (en)	2005-11-21	2005-12-28	Cambridge Biostability Ltd	Pharmaceutical device for the administration of substances to patients
AR054215A1 (es) *	2006-01-20	2007-06-13	Eriochem Sa	Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
EP1976486A1 (en) *	2006-01-27	2008-10-08	The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin	A method of producing porous microparticles
KR100917809B1 (ko) *	2006-05-22	2009-09-18	에스케이케미칼주식회사	우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물
GB0613925D0 (en)	2006-07-13	2006-08-23	Unilever Plc	Improvements relating to nanodispersions
EP2121088B1 (en)	2007-03-09	2016-07-13	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
AU2008245710B2 (en) *	2007-04-27	2013-10-17	Endo Pharmaceuticals Solutions Inc.	Implant device release agents and methods of using same
PT103743B (pt) *	2007-05-16	2013-01-15	Hovione Farmaciencia S A	Processo para preparar derivados de 21-disódio fosfato de pregnanos.
GB0716591D0 (en) *	2007-08-24	2007-10-03	Vereniging Het Nl Kanker I	Composition
EP2190413B1 (en)	2007-08-24	2015-01-28	Stichting Het Nederlands Kanker Instituut	Compositions for the treatment of neoplastic diseases
AU2008311053B2 (en) *	2007-10-09	2012-08-30	Novartis Ag	Pharmaceutical formulation of valsartan
KR101024742B1 (ko) *	2007-12-31	2011-03-24	주식회사 삼양사	탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
US9801818B2 (en)	2007-12-31	2017-10-31	Samyang Biopharmaceuticals Corporation	Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
AU2009273747A1 (en) *	2008-07-25	2010-01-28	Alphapharm Pty Ltd	Atovaquone with a particle size diameter range (D90) of greater than 3 um to about 10 um
JP2012500788A (ja) *	2008-08-22	2012-01-12	スティヒティングヘットネーデルランドカンケルインスティテュート	組成物
US8685458B2 (en)	2009-03-05	2014-04-01	Bend Research, Inc.	Pharmaceutical compositions of dextran polymer derivatives
US9724664B2 (en)	2009-03-27	2017-08-08	Bend Research, Inc.	Spray-drying process
WO2012031129A2 (en)	2010-09-03	2012-03-08	Bend Research, Inc.	Spray-drying apparatus and methods of using the same
US9084944B2 (en)	2010-09-03	2015-07-21	Bend Research, Inc.	Spray-drying apparatus and methods of using the same
WO2012040502A1 (en)	2010-09-24	2012-03-29	Bend Research, Inc.	High-temperature spray drying process and apparatus
JP2014511382A (ja)	2011-02-23	2014-05-15	コエルルウスリミテッド	フルマゼニル錯体、それを含む組成物、およびその使用
US9084727B2 (en)	2011-05-10	2015-07-21	Bend Research, Inc.	Methods and compositions for maintaining active agents in intra-articular spaces
CN103301095B (zh) *	2012-03-13	2016-04-13	中国科学院上海药物研究所	一种用于提高普罗布考口服吸收的多孔复合载药组合物及其制备方法
EP2863893B1 (en) *	2012-06-22	2025-08-27	UniSA Ventures Pty Ltd	Method and composition for delivering a compound through a biological barrier
WO2015089105A1 (en)	2013-12-09	2015-06-18	Respira Therapeutics, Inc.	Pde5 inhibitor powder formulations and methods relating thereto
EP3154528B1 (en) *	2014-06-11	2023-04-05	SpecGx LLC	Spray dried compositions having different dissolution profiles and processes for their preparation
CA2962719A1 (en)	2014-10-31	2016-05-06	Bend Research Inc.	Process for forming active domains dispersed in a matrix
CA2971440C (en) *	2014-12-18	2024-02-13	Windgap Medical, Inc.	Method and compositions for dissolving or solubilizing therapeutic agents
US10751319B2 (en) *	2015-06-04	2020-08-25	Crititech, Inc.	Collection device and methods for use
CN108778244B (zh)	2015-09-16	2022-04-01	Dfb索里亚有限责任公司	药物纳米颗粒的递送及其使用方法
WO2017176628A1 (en)	2016-04-04	2017-10-12	Crititech, Inc.	Methods for solid tumor treatment
US10076494B2 (en)	2016-06-16	2018-09-18	Dexcel Pharma Technologies Ltd.	Stable orally disintegrating pharmaceutical compositions
KR101965708B1 (ko) *	2016-08-30	2019-04-04	이화여자대학교 산학협력단	스폰지 유사 구조를 갖는 고분자 미립자 및 이의 제조방법
CN118948828A (zh)	2017-03-15	2024-11-15	Dfb索里亚有限责任公司	使用紫杉烷纳米颗粒治疗皮肤恶性肿瘤的局部疗法
CN110730679A (zh)	2017-06-09	2020-01-24	克里蒂泰克公司	囊内注射抗肿瘤颗粒治疗上皮囊肿
CN110799176A (zh)	2017-06-14	2020-02-14	克里蒂泰克公司	治疗肺部疾病的方法
RU2020110399A (ru)	2017-10-03	2021-11-09	Крититек, Инк.	Местная доставка противоопухолевых частиц в комбинации с системной доставкой иммунотерапевтических агентов для лечения рака
BR112020013750A8 (pt)	2018-01-05	2022-10-18	Impel Neuropharma Inc	Dispensação intranasal de olanzapina por dispositivo olfativo de precisão
KR102852740B1 (ko)	2018-02-02	2025-08-29	알렉스자 파마스티칼즈, 인크.	전기적 응축 에어로졸 디바이스
EP3765035A4 (en)	2018-03-16	2021-10-27	DFB Soria, LLC	TOPICAL THERAPY FOR THE TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) AND COLD CANCER USING TAXANE NANOPARTICLES
MX2021009038A (es)	2019-01-29	2021-08-16	Bayer Healthcare Llc	Composiciones topicas de naproxeno en gel.
CA3138885A1 (en) *	2019-05-10	2020-11-19	Anomera Inc.	Porous cellulose microparticles and methods of manufacture thereof
EP4037666B1 (en)	2020-12-08	2024-05-01	Ruminant Biotech Corp Limited	Improvements to devices and methods for delivery of substances to animals
CN113081971A (zh) *	2021-05-14	2021-07-09	江西中医药大学	一种中药多孔核壳型复合粒子粉体及其制备方法和应用
CN117538462B (zh) *	2024-01-10	2024-03-26	地奥集团成都药业股份有限公司	一种氨氯地平贝那普利胶囊有关物质的检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1265615A (no) *	1970-09-10	1972-03-01
NL7313626A (nl) †	1973-10-04	1975-04-08	Philips Nv	Gecombineerde inrichting voor het produceren en sselen van warmte met een warmte ver- ende inrichting.
GB8322007D0 (en) †	1983-08-16	1983-09-21	Wellcome Found	Pharmaceutical delivery system
IL82245A (en) *	1986-04-25	1990-07-26	Basf Ag	Preparation of spray-dried granules of active ingredients
EP0655237A1 (de) *	1993-11-27	1995-05-31	Hoechst Aktiengesellschaft	Medizinische Aerosolformulierung
US5762961A (en) *	1996-02-09	1998-06-09	Quadrant Holdings Cambridge Ltd.	Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
EP0954282B1 (en) *	1997-01-16	2005-01-19	Massachusetts Institute Of Technology	Preparation of particles for inhalation
ES2205560T5 (es) *	1997-09-29	2013-04-16	Novartis Ag	Preparaciones estabilizadas para usar en inhaladores de dosis medida
JP4758525B2 (ja) *	1998-03-20	2011-08-31	武田薬品工業株式会社	生理活性ポリペプチドの徐放性製剤およびその製造法
US6423345B2 (en) †	1998-04-30	2002-07-23	Acusphere, Inc.	Matrices formed of polymer and hydrophobic compounds for use in drug delivery

2000
- 2000-05-25 DE DE60024811T patent/DE60024811T3/de not_active Expired - Lifetime
- 2000-05-25 HK HK03101310.8A patent/HK1048956B/zh not_active IP Right Cessation
- 2000-05-25 ES ES00939365T patent/ES2250141T5/es not_active Expired - Lifetime
- 2000-05-25 BR BR0010984-3A patent/BR0010984A/pt not_active IP Right Cessation
- 2000-05-25 CN CNB008081611A patent/CN1240373C/zh not_active Expired - Fee Related
- 2000-05-25 AT AT00939365T patent/ATE312601T1/de active
- 2000-05-25 DK DK00939365T patent/DK1180020T4/da active
- 2000-05-25 EP EP00939365A patent/EP1180020B2/en not_active Expired - Lifetime
- 2000-05-25 CA CA002371836A patent/CA2371836C/en not_active Expired - Fee Related
- 2000-05-25 KR KR1020077012286A patent/KR100883477B1/ko not_active Expired - Fee Related
- 2000-05-25 KR KR1020017015052A patent/KR100752000B1/ko not_active Expired - Fee Related
- 2000-05-25 JP JP2000620939A patent/JP4722295B2/ja not_active Expired - Fee Related
- 2000-05-25 MX MXPA01012106A patent/MXPA01012106A/es active IP Right Grant
- 2000-05-25 WO PCT/US2000/014578 patent/WO2000072827A2/en not_active Ceased
- 2000-05-25 NZ NZ516083A patent/NZ516083A/en not_active IP Right Cessation
- 2000-05-25 IL IL14665900A patent/IL146659A0/xx unknown
- 2000-05-25 AU AU54459/00A patent/AU768022B2/en not_active Ceased
- 2000-05-29 TW TW089110363A patent/TWI274589B/zh not_active IP Right Cessation
2001
- 2001-11-21 IL IL146659A patent/IL146659A/en not_active IP Right Cessation
- 2001-11-26 NO NO20015753A patent/NO323761B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK1180020T4 (da)	2009-10-05
NO20015753L (no)	2002-01-28
EP1180020B2 (en)	2009-06-24
MXPA01012106A (es)	2003-06-30
WO2000072827A2 (en)	2000-12-07
IL146659A0 (en)	2002-07-25
KR100752000B1 (ko)	2007-08-28
DK1180020T3 (da)	2006-03-27
DE60024811T3 (de)	2010-01-07
HK1048956B (zh)	2006-07-28
NZ516083A (en)	2003-08-29
KR20020011992A (ko)	2002-02-09
ATE312601T1 (de)	2005-12-15
HK1048956A1 (en)	2003-04-25
IL146659A (en)	2010-05-31
WO2000072827A3 (en)	2001-01-25
CN1365274A (zh)	2002-08-21
HK1094775A1 (zh)	2007-04-13
CN1240373C (zh)	2006-02-08
ES2250141T5 (es)	2009-11-05
EP1180020A2 (en)	2002-02-20
JP2003500438A (ja)	2003-01-07
JP4722295B2 (ja)	2011-07-13
KR20070069219A (ko)	2007-07-02
AU5445900A (en)	2000-12-18
DE60024811T2 (de)	2006-09-14
DE60024811D1 (de)	2006-01-19
NO323761B1 (no)	2007-07-02
CA2371836C (en)	2006-01-31
TWI274589B (en)	2007-03-01
CA2371836A1 (en)	2000-12-07
KR100883477B1 (ko)	2009-02-16
EP1180020B1 (en)	2005-12-14
ES2250141T3 (es)	2006-04-16
BR0010984A (pt)	2002-04-30
AU768022B2 (en)	2003-11-27
WO2000072827A9 (en)	2002-01-31

Publication	Publication Date	Title
NO20015753D0 (no)	2001-11-26	Poröse legemiddelmatriser og fremgangsmåter for deres fremstilling
RU2420290C2 (ru)	2011-06-10	Твердые, пригодные для орального употребления фармацевтические формы применения, содержащие ривароксабан с модифицированным высвобождением
WO2001095877A3 (en)	2002-05-02	Porous celecoxib matrices and methods of manufacture thereof
JP2000229846A (ja)	2000-08-22	放出制御型剤形
CO5261593A1 (es)	2003-03-31	Formulaciones de entecavir de dosis bajas y uso
DE69812690D1 (de)	2003-04-30	Arzneistoffverabreichungssystem auf basis von flüssigkristall-strukturen
CO5560580A2 (es)	2005-09-30	Formulaciones de sucralosa para disumular sabores desagradables
JPS61267517A (ja)	1986-11-27	記憶障害の経皮治療製剤
JPS59167512A (ja)	1984-09-21	ニモジピン液体組成物
EA200000154A1 (ru)	2000-10-30	Способ солюбилизации фармацевтически активных ингредиентов в воде и в водных носителях
CN1505513A (zh)	2004-06-16	注射用西洛他唑水性制剂
EP1295595A4 (en)	2008-04-02	TABLET RAPIDLY DISINTEGRATING IN THE MOUTH AND CORRESPONDING PRODUCTION PROCESS
AU2003235156B9 (en)	2003-10-27	Solid dispersion composition
BRPI0810113B1 (pt)	2020-03-24	Método para preparação de um extrato seco de pelargonium sidoides e/ou pelargonium reniforme com solubilidade melhorada em solventes fisiologicamente compatíveis
Minocha et al.	2019	SOlubility enhancement of poorly water soluble drugs by various techniques
TH78112A (th)	2006-06-22	เนื้อสารยารูพรุน และวิธีการของการผลิตของสิ่งเหล่านั้น
KR100981750B1 (ko)	2010-09-10	분무-건조 과립 및 그의 제조방법
EP0323762B1 (fr)	1993-07-14	Nouvelles compositions anti-tussives et leur procédé d'obtention
JP2616946B2 (ja)	1997-06-04	肝類洞小孔拡張・増加剤
JP5691142B2 (ja)	2015-04-01	ベンズイミダゾール系注射剤
ES2230671T3 (es)	2005-05-01	Procedimiento para eliminar disolventes de alto punto de ebullicion de formulaciones de farmacos por secado a vacio.
CO5560534A2 (es)	2005-09-30	Formulaciones farmaceuticas
JPH07291863A (ja)	1995-11-07	腎保護作用剤
Harindran	0	ENHANCEMENT OF BIOA DIFFERENT SOLUBILIT TECHNIQUES
CN107281294A (zh)	2017-10-24	一种山楂叶总黄酮渗透泵控释片及其制备方法

Legal Events

Date	Code	Title	Description
2016-12-27	MM1K	Lapsed by not paying the annual fees